ATE204883T1 - Synthetische polysaccharide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen - Google Patents

Synthetische polysaccharide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen

Info

Publication number
ATE204883T1
ATE204883T1 AT97928337T AT97928337T ATE204883T1 AT E204883 T1 ATE204883 T1 AT E204883T1 AT 97928337 T AT97928337 T AT 97928337T AT 97928337 T AT97928337 T AT 97928337T AT E204883 T1 ATE204883 T1 AT E204883T1
Authority
AT
Austria
Prior art keywords
production
pharmaceutical compositions
compositions containing
synthetic polysaccharides
polysaccharides
Prior art date
Application number
AT97928337T
Other languages
English (en)
Inventor
Philippe Duchaussoy
Jean-Marc Herbert
Guy Jaurand
Maurice Petitou
Boeckel Constant Van
Original Assignee
Sanofi Synthelabo
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo, Akzo Nobel Nv filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of ATE204883T1 publication Critical patent/ATE204883T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
AT97928337T 1996-06-14 1997-06-11 Synthetische polysaccharide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen ATE204883T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9607457A FR2749849B1 (fr) 1996-06-14 1996-06-14 Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
PCT/FR1997/001048 WO1997047659A1 (fr) 1996-06-14 1997-06-11 Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
ATE204883T1 true ATE204883T1 (de) 2001-09-15

Family

ID=9493087

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97928337T ATE204883T1 (de) 1996-06-14 1997-06-11 Synthetische polysaccharide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen

Country Status (15)

Country Link
US (1) US7919614B2 (de)
EP (1) EP0904299B1 (de)
JP (1) JP3501813B2 (de)
AT (1) ATE204883T1 (de)
AU (1) AU3266797A (de)
BR (1) BR9709722B1 (de)
CA (1) CA2258146C (de)
CY (1) CY2281B1 (de)
DE (1) DE69706418T2 (de)
DK (1) DK0904299T3 (de)
ES (1) ES2163171T3 (de)
FR (1) FR2749849B1 (de)
NO (1) NO319037B1 (de)
PT (1) PT904299E (de)
WO (1) WO1997047659A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751334B1 (fr) * 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2773804B1 (fr) * 1998-01-19 2000-02-18 Sanofi Sa Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
EP1574516A1 (de) * 2004-03-05 2005-09-14 Sanofi-Aventis Antithrombotische Verbindungen
JP4796758B2 (ja) * 2004-08-24 2011-10-19 学校法人 京都産業大学 組成物及びそれを含有する抗腫瘍剤
TWI403334B (zh) 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
CN102046781A (zh) * 2008-05-30 2011-05-04 动量制药公司 糖结构以及制造和使用此类结构的方法
FR2949115B1 (fr) * 2009-08-14 2012-11-02 Sanofi Aventis OLIGOSACCHARIDES N-SULFATES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2949114B1 (fr) * 2009-08-14 2011-08-26 Sanofi Aventis OCTASACCHARIDES N-ACYLES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2970969B1 (fr) * 2011-01-27 2013-10-18 Sanofi Aventis Oligosaccharides 3-o-alkyles activateurs des recepteurs des fgfs, leur preparation et leur application en therapeutique
EP2578594A1 (de) * 2011-10-04 2013-04-10 Sanofi Verfahren zur Herstellung von L-Iduronsäure mittels einer Decarboxylierung/intramolekulare Zyklisierungs-Tandemreaktion
WO2021211441A1 (en) * 2020-04-13 2021-10-21 The Board Of Regents Of The University Of Oklahoma Modified sugar polymers with low anticoagulant activity and therapeutic activity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378829A (en) * 1990-04-23 1995-01-03 Akzo N.V. Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type
US5529985A (en) * 1990-04-23 1996-06-25 Akzo Nobel Nv Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type
US5382570A (en) * 1990-04-23 1995-01-17 Akzo, N.V. Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type
US5668274A (en) * 1991-04-23 1997-09-16 Akzo Nobel N.V. Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type

Also Published As

Publication number Publication date
JPH11513061A (ja) 1999-11-09
CA2258146C (fr) 2003-10-07
DE69706418D1 (de) 2001-10-04
NO985831D0 (no) 1998-12-11
CA2258146A1 (fr) 1997-12-18
NO319037B1 (no) 2005-06-06
US7919614B2 (en) 2011-04-05
EP0904299A1 (de) 1999-03-31
FR2749849A1 (fr) 1997-12-19
DE69706418T2 (de) 2002-05-29
US20040068108A1 (en) 2004-04-08
BR9709722A (pt) 2000-01-25
EP0904299B1 (de) 2001-08-29
FR2749849B1 (fr) 1998-09-04
JP3501813B2 (ja) 2004-03-02
CY2281B1 (en) 2003-07-04
AU3266797A (en) 1998-01-07
PT904299E (pt) 2002-02-28
NO985831L (no) 1999-02-11
BR9709722B1 (pt) 2010-12-14
DK0904299T3 (da) 2001-12-17
ES2163171T3 (es) 2002-01-16
WO1997047659A1 (fr) 1997-12-18

Similar Documents

Publication Publication Date Title
NZ333721A (en) Pharmaceutically acceptable synthetic polysaccharides
DE69706418D1 (de) Synthetische polysaccharide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
MX9300443A (es) Metodo para elaborar papel y producto resultante.
FR2684385B1 (fr) Heparosanes-n,o-sulfates de haute masse moleculaire, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE256137T1 (de) Keratansulfatoligosaccharid-fraktion und sie enthaltendes medikament
PT94657A (pt) Processo para a preparacao de uma composicao de mistura de base polimerica contendo amido desestruturado e de produtos que a contem
KR880005936A (ko) 저분자량 글루코스아미노글리칸의 조절된 제조방법
UY28016A1 (es) Mezclas de polisacáridos derivados de heparina, su preparacion y las composiciones farmaceuticas que las contienen.
ATE207365T1 (de) Polyribosylribitol-phosphat enthaltende haemophilus-influenzae-typ-b-impfstoffzubereitu g und verfahren zu deren herstellung
ATE209219T1 (de) Synthetische polysaccharide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE3850795D1 (de) Polysaccharid und Verfahren zu seiner Herstellung.
DE69805757D1 (de) Polysaccharid, mikroorganismus und verfahren zu dessen herstellung, dieses enthaltende zusammensetzung und verwendung
DE69219264D1 (de) Polysaccharid, seine Verwendungen, der Fermentationsprozess und der Stamm von Pseudomonas zu seiner Herstellung
DE69218438D1 (de) Dermatansulfatoligosaccharide, Verfahren zu ihrer Herstellung und diese enthaltende phamazeutische Zusammensetzungen
ES2086295T3 (es) Celulosa modificada para membranas de dialisis biocompatibles.
NO934044L (no) Genetisk kontroll av acetylering og pyruvylering av xantanbaserte poly-sakkaridpolymerer
Lindahl Approaches to the synthesis of heparin
ATE83811T1 (de) Cellulosefaserbahnen.
DE69015215D1 (de) Polysaccharid und Wasserabsorptionsmittel, Feuchtigkeitsabsorptionsmittel, Feuchthaltemittel oder Verdickungsmittel, bestehend hauptsächlich aus dem Polysaccharid und Kulturverfahren zu seiner Herstellung mittels eines Mikroorganismus.
DE3785895D1 (de) Oxiran-pseudooligosaccharide, verfahren zu deren herstellung, deren verwendung und pharmazeutische praeparate.
ATE32906T1 (de) Anisotrope zusammensetzungen aus celluloseestern, verfahren zu deren herstellungen, fasern aus celluloseestern oder aus zellstoff.
RUAN et al. Development and application of anti-adherent evaluation model of H pylori adherent to MKN45 cell
ECSP941072A (es) Una composicion y un metodo para formar un recubrimiento sobre productos vegetales
ATE8240T1 (de) Verdickte waessrige saure loesungen und ihre verwendung, insbesondere zur entkalkung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification